Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction.
A rapid twin-column gas chromatographic (GC) method for simultaneous screening and determination of commonly prescribed benzodiazepines and other new anxiolytics from plasma is described. Identical fused-silica Ultra 2 (5% phenyl methyl silicone) columns were connected to nitrogen-phosphorus and electron-capture detectors. The drugs were isolated from 1 ml of plasma by solid-phase extraction (SPE) onto a C8 reversed-phase sorbent and recovered with 0.5% acetic acid in methanol. The eluate was reconstituted with isopropanol which was found suitable for on-column injection. Prazepam was used as internal standard. The method was found appropriate for the quantification in a single run of alpidem, alprazolam, buspirone, chlordiazepoxide, clobazam, clotiazepam, diazepam, estazolam, flunitrazepam, lorazepam, midazolam, oxazepam, tofisopam, triazolam, and zolpidem within 30 min. Limits of quantification allow toxicological or pharmacological determinations, except for buspirone: only toxic blood levels can be quantified by this method. This first SPE of imidazopyridines (alpidem and zolpidem) provides faster, more efficient and cheaper sample preparation than the traditional liquid-liquid procedure. This GC analysis of alpidem and zolpidem is also the first described procedure for simultaneous quantification of all different classes of anxiolytics.
Gaillard
Y
Y
Laboratoire Central de Pharmacologie et Toxicologie, Hôpital de Bellevue, Saint-Etienne, France.
Gay-Montchamp
J P
JP
Ollagnier
M
M
D014151:Anti-Anxiety Agents / Q000097:blood*; D001569:Benzodiazepines; D002065:Buspirone / Q000097:blood; D002849:Chromatography, Gas; D004563:Electrochemistry; D006801:Humans; D006993:Hypnotics and Sedatives / Q000097:blood; D007093:Imidazoles / Q000097:blood; D007202:Indicators and Reagents; D011725:Pyridines / Q000097:blood; D012044:Regression Analysis; D000077334:Zolpidem
D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives; D007093:Imidazoles; D007202:Indicators and Reagents; D011725:Pyridines; D001569:Benzodiazepines; D000077334:Zolpidem; C052036:alpidem; D002065:Buspirone